These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of Wnt inhibitors in pancreatic cancer.
    Author: Wall I, Schmidt-Wolf IG.
    Journal: Anticancer Res; 2014 Oct; 34(10):5375-80. PubMed ID: 25275031.
    Abstract:
    BACKGROUND/AIM: Activated Wnt signaling in cancer cells leads to cell proliferation. It has been shown that the Wnt pathway is activated in pancreatic adenocarcinoma cells. Therefore, we tested the effect of Wnt inhibitors in human and murine pancreatic cancer cell lines. MATERIALS AND METHODS: The Wnt inhibitors ethacrynic acid (EA), ciclopirox olamine (CIC), piroctone olamine (PO) and griseofulvin (GF) were tested in murine and human pancreatic cancer cell lines with the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay. RESULTS: We showed that the Wnt inhibitors significantly reduced cell viability in murine, as well as human pancreatic cancer cell lines. CONCLUSION: These results may lead to a new therapeutic option with Wnt inhibitors for patients with pancreatic adenocarcinoma.
    [Abstract] [Full Text] [Related] [New Search]